Open original FDA record ↗Recall record
- FDA identifier
- Z-1309-2008
- Company in FDA record
- National Biological Corp
- FDA classification date
- Aug 28, 2008
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
Software allows operator to override "low line voltage" error warning and store light intensity value.
Source facts
- Action
- National Biological sent an "Important safety reminders for your Houva DermaSense phototherapy device" letters, dated 2/11/08 to users. It states that the user should collect a "Profile" of the light energy and record it on a daily/weekly flow chart. The chart should be in plain view so each operator can clearly determine the units output. If an error message appears in the display panel, treatment should not be continued unless the phototherapy booth operator was able to identify and correct the cause of the error. Make sure both breakers are in the "ON" position before starting up the unit each morning and before giving treatment.
- Initiated
- 2008-02-19
- Root cause
- Software design
- Terminated
- 2011-09-20
- Distribution
- Worldwide distribution --- USA including states of: CA, DE, FL, GA, ID, IL, IN, MA, MI, MN, NC, NH, NY, OH, OR, PA, TX, VA, WA and WI, and country of Canada.
- Recall number
- Z-1309-2008
- Recall status
- Terminated
- CDRH record ID
- 68319
- FDA classified
- 2008-08-28
- Recall event number
- 46834